InVivo AI

InVivo AI is developing new computational tools to adapt to the unique constraints of drug discovery, enabling our partners to identify better therapeutic candidates more quickly. Building on research conducted by the founding team of the Montreal Institute for Learning Algorithms and pioneering the use of meta-learning and few-shot learning in drug design, we are able to address the small and noisy datasets characteristic of many of the most critical predictive tasks in drug discovery.InVivo AI is collaborating with industry-leading partners to design candidate drugs optimized for pre-specified criteria, often utilizing datasets and disease models that are inaccessible through traditional learning methods, allowing for rapid iteration toward IND-ready assets.